Vicapsys Life Sciences, Inc.
VICP · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $60 | $24 | $8 | $9 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $1 | $0 | $0 | $0 |
| Enterprise Value | $61 | $24 | $8 | $9 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$1 | -$1 | -$1 | -$0 |
| % Margin | – | – | – | – |
| Net Income | -$1 | -$1 | -$1 | -$0 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.029 | -0.034 | -0.032 | -0.013 |
| % Growth | 15.8% | -5.9% | -141% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | $0 | -$0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |